Literature DB >> 26022962

Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.

Caroline Kannengiesser1, Raphael Borie2, Christelle Ménard3, Marion Réocreux3, Patrick Nitschké4, Steven Gazal5, Hervé Mal6, Camille Taillé7, Jacques Cadranel8, Hilario Nunes9, Dominique Valeyre9, Jean François Cordier10, Isabelle Callebaut11, Catherine Boileau12, Vincent Cottin10, Bernard Grandchamp12, Patrick Revy13, Bruno Crestani14.   

Abstract

Pulmonary fibrosis is a fatal disease with progressive loss of respiratory function. Defective telomere maintenance leading to telomere shortening is a cause of pulmonary fibrosis, as mutations in the telomerase component genes TERT (reverse transcriptase) and TERC (RNA component) are found in 15% of familial pulmonary fibrosis (FPF) cases. However, so far, about 85% of FPF remain genetically uncharacterised.Here, in order to identify new genetic causes of FPF, we performed whole-exome sequencing, with a candidate-gene approach, of 47 affected subjects from 35 families with FPF without TERT and TERC mutations.We identified heterozygous mutations in regulator of telomere elongation helicase 1 (RTEL1) in four families. RTEL1 is a DNA helicase with roles in DNA replication, genome stability, DNA repair and telomere maintenance. The heterozygous RTEL1 mutations segregated as an autosomal dominant trait in FPF, and were predicted by structural analyses to severely affect the function and/or stability of RTEL1. In agreement with this, RTEL1-mutated patients exhibited short telomeres in comparison with age-matched controls.Our results provide evidence that heterozygous RTEL1 mutations are responsible for FPF and, thereby, extend the clinical spectrum of RTEL1 deficiency. Thus, RTEL1 enlarges the number of telomere-associated genes implicated in FPF.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26022962     DOI: 10.1183/09031936.00040115

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  60 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 2.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

3.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

Review 4.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

5.  Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.

Authors:  Chad A Newton; David Zhang; Justin M Oldham; Julia Kozlitina; Shwu-Fan Ma; Fernando J Martinez; Ganesh Raghu; Imre Noth; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405

Review 6.  Extrahematopoietic manifestations of the short telomere syndromes.

Authors:  Kristen E Schratz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

7.  Licence to kill senescent cells in idiopathic pulmonary fibrosis?

Authors:  Arnaud A Mailleux; Bruno Crestani
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

8.  Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies.

Authors:  Shirleny R Cardoso; Alicia C M Ellison; Amanda J Walne; David Cassiman; Manoj Raghavan; Bhuvan Kishore; Philip Ancliff; Carmen Rodríguez-Vigil; Bieke Dobbels; Ana Rio-Machin; Ahad F H Al Seraihi; Nikolas Pontikos; Hemanth Tummala; Tom Vulliamy; Inderjeet Dokal
Journal:  Haematologica       Date:  2017-05-11       Impact factor: 9.941

9.  Whole-Exome Sequencing Insights into Adult Pulmonary Fibrosis. Repeating the Telomere Theme.

Authors:  Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2017-07-01       Impact factor: 21.405

10.  Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.

Authors:  Jonathan A Kropski; Lisa R Young; Joy D Cogan; Daphne B Mitchell; Lisa H Lancaster; John A Worrell; Cheryl Markin; Na Liu; Wendi R Mason; Tasha E Fingerlin; David A Schwartz; William E Lawson; Timothy S Blackwell; John A Phillips; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.